Fortress Biotech Inc (FRA:CNB1)
€ 4.131 0 (0%) Market Cap: 32.09 Mil Enterprise Value: 30.08 Mil PE Ratio: 0 PB Ratio: 2.19 GF Score: 62/100

Fortress Biotech Inc Corporate Update Presentation at Benzinga Healthcare Small Cap Conference (Virtual) Transcript

Sep 30, 2021 / 03:30PM GMT
Release Date Price: €45 (-5.06%)
Brent Slava
Benzinga - Moderator

Presentation at Benzinga Healthcare Small Cap Conference (Virtual)
Sep 30, 2021 / 03:30PM GMT

=====================
Corporate Participants
=====================
* Lindsay Rosenwald
Fortress Biotech, Inc. - President, Chairman, CEO

=====================
Conference Call Participants
=====================
* Brent Slava
Benzinga - Moderator

=====================
-

Lindsay Rosenwald
Fortress Biotech, Inc. - President, Chairman, CEO

The show will continue, here we go. We're jumping right into it. Next presenter is from a company called Fortress Bio. It's ticker FBIO, and I'm going to be welcoming on here, the Chairman, Lindsay Rosenwald. Lindsay, how are you?

-

Brent Slava
Benzinga - Moderator

Hey, Brent. I'm good, how are you?

-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot